PACIRA BIOSCIENCES, INC. Other Adjustments to Income, Discontinued Operations
PACIRA BIOSCIENCES, INC. (PCRX) reported Other Adjustments to Income, Discontinued Operations of -$1.97 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OtherAdjustmentsToIncomeDiscontinuedOperations · last filed 2020-02-21
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for the quarter ending 2018-12-31 was -$120.00K.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for the quarter ending 2018-09-30 was $40.00K.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for the quarter ending 2018-06-30 was $40.00K.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for the quarter ending 2018-03-31 was $40.00K.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for fiscal 2019 was -$1.97M.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- PACIRA BIOSCIENCES, INC. other adjustments to income, discontinued operations for fiscal 2017 was $494.00K.
| Period end | Other Adjustments to Income, Discontinued Operations 3 month | Other Adjustments to Income, Discontinued Operations 6 month | Other Adjustments to Income, Discontinued Operations 9 month | Other Adjustments to Income, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$1.97M 10-K · filed 2020-02-21 | |||
| 2018-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$80.00K derived: sum of 2 quarters · filed 2020-02-21 | -$40.00K derived: sum of 3 quarters · filed 2020-02-21 | $0.00 10-K · filed 2020-02-21 |
| 2018-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $80.00K derived: sum of 2 quarters · filed 2018-11-01 | $120.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $80.00K 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $40.00K 10-Q · filed 2018-05-03 | |||
| 2017-12-31 | $494.00K 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |